Press release
-
Press Release
Massimo Group Announces Bitcoin Treasury Strategy
GARLAND, Texas, Dec. 1, 2025 /PRNewswire/ — Massimo Group (NASDAQ: MAMO) today announced that its Board of Directors has approved…
Read More » -
Press Release
Commvault Achieves AWS Resilience Competency Status
Delivers validated expertise in helping customers strengthen cyber resilience and recovery across AWS and hybrid-cloud environments TINTON FALLS, N.J., Dec. 1,…
Read More » -
Press Release
Kurv Rolls Out All-in-One Kurv Merchant App and Tap to Pay on Android Feature
CLEVELAND, Dec. 1, 2025 /PRNewswire/ — Kurv, formerly known as Electronic Merchant Systems, announced today its all-in-one Kurv Merchant App,…
Read More » -
Press Release
BitMine Immersion (BMNR) Announces ETH Holdings Reach 3.73 Million Tokens, and Total Crypto and Cash Holdings of $12.1 Billion
BitMine now owns more than 3.0% of the ETH token supply, two-thirds of the way to the ‘Alchemy of 5%’…
Read More » -
Press Release
Fathom Holdings Divests LiveBy Assets to Move Concierge
Fathom to Receive $3.0 Million Cash CARY, N.C., Dec. 1, 2025 /PRNewswire/ — Fathom Holdings Inc. (Nasdaq: FTHM) (“Fathom” or…
Read More » -
Press Release
JPIX Selects XKL for IX Network Infrastructure Upgrade
JPIX Extends 400G Network Infrastructure with XKL’s DWDM Technology REDMOND, Wash., Dec. 1, 2025 /PRNewswire/ — Japan Internet Xing Co.,…
Read More » -
Press Release
Opera browsers now ship with a new generation of AI powered by Google
OSLO, Norway, Dec. 1, 2025 /PRNewswire/ — The browser innovator and agentic AI company Opera (NASDAQ: OPRA) is rolling out new…
Read More » -
Press Release
YY Group Secures 3-Year Facility Maintenance Contract with a Major International Bank
New Partnership Broadens Client Base and Enhances Business Quality with Stable, Long-Term Revenue SINGAPORE, Dec. 1, 2025 /PRNewswire/ — YY…
Read More » -
Press Release
Galmed Issues CEO Letter to Shareholders
TEL AVIV, Israel, Dec. 1, 2025 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical…
Read More »